Non Viral Vectors in Gene Therapy- An Overview

Cited by papers we hold 13

• Emerging Therapies for Hepatocellular Carcinoma (HCC) · 2022
  No notice
• High-throughput 5′ UTR engineering for enhanced protein production in non-viral gene therapies · 2021
  No notice
• CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future · 2020
  No notice
• CRISPR-Cas9 DNA Base-Editing and Prime-Editing · 2020
  No notice
• Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems · 2020
  No notice
• SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs · 2020
  No notice
• Opportunities and Challenges in the Delivery of mRNA-Based Vaccines · 2020
  No notice
• Gene Therapy Tools for Brain Diseases · 2019
  No notice
• Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme · 2019
  No notice
• Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics · 2018
  No notice
• Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers · 2018
  No notice
• Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye · 2018
  No notice
• New Advances in General Biomedical Applications of PAMAM Dendrimers · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.